On January 17, 2024, the company announced that it has extended its plan duration till June 30, 2024.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.371 USD | -7.99% | -3.46% | -49.23% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.23% | 2.8Cr | |
+9.54% | 11TCr | |
+13.14% | 11TCr | |
-7.42% | 2.22TCr | |
-1.48% | 2.13TCr | |
-4.36% | 1.88TCr | |
-6.02% | 1.75TCr | |
-39.36% | 1.72TCr | |
+6.16% | 1.41TCr | |
+34.61% | 1.22TCr |
- Stock Market
- Equities
- ENLV Stock
- News Enlivex Therapeutics Ltd.
- Enlivex Therapeutics Ltd.'s Equity Buyback Plan Extended till June 30, 2024.